Literature DB >> 13062573

[Excision of skin in diagnosis of Fabry's angiokeratoma with cardio-vasorenal syndrome as phosphatide storage disease].

H HORNBOSTEL, K SCRIBA.   

Abstract

Entities:  

Keywords:  ANGIOKERATOMA; PHOSPHOLIPIDS/metabolism

Mesh:

Substances:

Year:  1953        PMID: 13062573     DOI: 10.1007/bf01478472

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  2 in total

1.  Angiokeratoma corporis diffusum (universale) Fabry, as a sign of an unknown internal disease; two autopsy reports.

Authors:  A W M POMPEN; M RUITER; H J G WYERS
Journal:  Acta Med Scand       Date:  1947-06-30

2.  [Angiokeratoma corporis diffusum universale (Fabry) with cardio-vaso-renal symptom complex as general disease].

Authors:  H HORNBOSTEL; W SPIER; H KOCH
Journal:  Arztl Wochensch       Date:  1951-01-19
  2 in total
  5 in total

1.  [Angiokeratoma corporis diffusum (Fabry) with cerebral manifestations].

Authors:  A HOFMANN; W HAUSER
Journal:  Dtsch Z Nervenheilkd       Date:  1962

2.  [On corneal dystrophy in genodermatoses with special reference to palmar and plantar keratosis. (Clinical, genetic and histological studies)].

Authors:  A FRANCESCHETTI; C J THIER
Journal:  Albrecht Von Graefes Arch Ophthalmol       Date:  1961

3.  [Neurological symptoms in Fabry's disease. Report of a case with neuromuscular symptoms and review of the literature].

Authors:  H Pilz; E Volles; H A Paul; A Denden
Journal:  Z Neurol       Date:  1972

4.  The Genetics of Angiokeratoma Corporis Diffusum (Fabry's Disease) and Its Linkage Relations with the Xg Locus.

Authors:  J M Opitz; F C Stiles; D Wise; R R Race; R Sanger; G R Von Gemmingen; R R Kierland; E G Cross; W P De Groot
Journal:  Am J Hum Genet       Date:  1965-07       Impact factor: 11.025

5.  A Novel Rapid MALDI-TOF-MS-Based Method for Measuring Urinary Globotriaosylceramide in Fabry Patients.

Authors:  Fahad J Alharbi; Tarekegn Geberhiwot; Derralynn A Hughes; Douglas G Ward
Journal:  J Am Soc Mass Spectrom       Date:  2016-01-21       Impact factor: 3.109

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.